[AQST] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- 33.14%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 50,583 47,680 50,832 45,849 52,609 67,430 66,918 -4.55%
PBT -7,625 -54,410 -70,539 -55,783 -66,246 -61,376 -8,943 -2.62%
Tax 245 5,792 19,497 9,579 6,413 -4,731 7,707 -43.70%
NP -7,870 -60,202 -90,036 -65,362 -72,659 -61,376 -8,943 -2.10%
Tax Rate - - - - - - - -
Total Cost 58,453 107,882 140,868 111,211 125,268 128,806 75,861 -4.24%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -15.56 -126.26 -177.12 -142.56 -138.11 -91.02 -13.36 2.57%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.13 -1.24 -2.36 -1.94 -2.87 -2.96 -0.45 -18.68%
EPS Diluted -0.13 -1.24 -2.36 -1.94 -2.87 -2.96 -0.45 -18.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.